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A B S T R A C T
Background: Ross River virus (RRV) is a zoonotic alphavirus transmitted by several mosquito species. Until
recently, endemic transmission was only considered possible in the presence of marsupial reservoirs.
Methods: RRV seroprevalence was investigated in placental mammals (including horses, cows, goats, pigs,
dogs, rats, and mice) in Fiji, where there are no marsupials. A total of 302 vertebrate serum samples were
collected from 86 households from 10 communities in Western Fiji.
Results: Neutralizing antibodies against RRV were detected in 28% to 100% of sera depending on the
species, and neutralization was strong even at high dilutions.
Conclusions: These results are unlikely to be due to cross-reactions. Chikungunya is the only other
alphavirus known to be present in the Pacific Islands, but it rarely spills over into non-humans, even
during epidemics. The study findings, together with a recent report of high RRV seroprevalence in
humans, strongly suggest that RRV is circulating in Fiji in the absence of marsupial reservoirs.
Considering that all non-human vertebrates present in Fiji are pan-global in distribution, RRV has the
potential to further expand its geographic range. Further surveillance of RRV and access to RRV
diagnostics will be critical for the early detection of emergence and outbreaks.
© 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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closely related to chikungunya virus (CHIKV), and can be
transmitted by various Culex and Aedes mosquitoes (Harley
et al., 2001). Marsupials, including macropods (kangaroos and
wallabies), possums, and bandicoots, are competent amplifiers
under experimental conditions (Harley et al., 2001). The possible
role of placental mammals and birds is poorly understood
(Stephenson et al., 2018). During epidemics, when there are many
viremic humans, direct human–mosquito–human transmission* Corresponding author at: Yale School of Public Health, Department of
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is endemic and enzootic in Australia, resulting in approximately
5000 reported human cases and economic losses of 5.7 million
Australian dollars every year (Australian Department of Health,
2019; Harley et al., 2001); symptoms include polyarthritis,
lethargy, and rash.
During the years 1979–1980, RRV caused large outbreaks in
humans across the South Pacific, with >500 000 cases reported
(Harley et al., 2001). The outbreak was thought to have been
seeded by an Australian who travelled to Fiji, where post-epidemic
seroprevalence reached 90% in some communities (Harley et al.,
2001; Aaskov et al., 1981). The outbreak was presumed to be
predominantly driven by an urban transmission cycle, and once it
had subsided, it was assumed that RRV transmission would ceaseciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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Figure 1. Ross River virus seropositivity in non-human vertebrates in Ba, Western
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reports of RRV infections in travelers returning from Fiji (Lau et al.,
2012) and recent human seroprevalence studies in Fiji (Aubry et al.,
2019), American Samoa (Lau et al., 2017), and French Polynesia
(Aubry et al., 2017) suggest ongoing endemic transmission. In 2013,
human samples from Fiji tested for anti-RRV antibodies using a
validated recombinant antigen-based microsphere immunoassayure 2. Ten communities from which human and non-human vertebrate samples were c
uman) and September to November 2015 (non-human vertebrate). A ‘household’ is define
mprise a community in Fiji. A ‘community’ is defined as a traditional Fijian (iTaukei) village, s
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ity of 59% in the greater Western Division, and seroconversion
patterns suggested ongoing endemic circulation in Fiji (Aubry et al.,
2019). These findings suggest endemic RRV transmission is
possible without marsupials, which has important implications
for the risk of global spread.
To investigate the role of non-marsupials in RRV transmission,
we studied the serological status of seven placental mammal
species for neutralizing antibodies of RRV in Fiji.
In September to November 2015, sera were collected from
cows, horses, goats, pigs, dogs, rats, and mice in Ba, Western Fiji
(Figure 1). Sera were tested for anti-RRV antibodies using a plaque
reduction neutralization test, as described previously (Gyawali
et al., 2019); the test was considered positive if plaque numbers
were reduced by >50%. In total, 302 non-human vertebrates were
sampled from 86 households (mean 3.5/household, range 1–13)
across 10 communities (mean 30.2/community, range 5–69).
Overall, 48% (146/302) were seropositive for RRV, including 100%
of horses (23/23), 62% of cows (47/76), 67% of pigs (2/3), 28% of
goats (24/85), 44% of dogs (27/61), 43% of rats (22/51), and 50% of
mice (1/2). Seropositive vertebrates were identified in all 10
communities in 74% (64/86) of households (Figure 2). These
findings support previous hypotheses (Aubry et al., 2019; Lau
et al., 2017) that enzootic RRV transmission can be maintained by
non-marsupial vertebrates.
The study findings are unlikely to be the result of cross-
reactivity with other alphaviruses. Ten percent of the positive
s-
a-
ollected from households in Ba, Western Fiji from September to December 2013
d as a unit of individuals occupying one house, in many instances a family, which
ettlement, or a suburban group of households, which comprise a subdivision in Fiji.laide from ClinicalKey.com.au by Elsevier on May 25, 
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continued to neutralize RRV, suggesting strong and specific
antibody binding (Gyawali et al., 2019). Although endemic
circulation of an unidentified alphavirus that cross-reacts with
RRV cannot be ruled out, we can exclude the majority, because
alphaviruses are classified by serological cross-reactivity (Calisher
et al., 1980). Sindbis virus belongs to a different alphavirus group
and does not cross-react with RRV. Of the Semliki Forest group,
only CHIKV has been reported in the Pacific Islands. CHIKV rarely
spills over into non-humans, even during epidemics. Barmah
Forest virus is not a good antigenic match with RRV and has never
been described outside of Australia. In the context of recent
seroprevalence results in humans in Fiji, RRV is by far the most
likely explanation for our findings.
Serological surveys cannot determine which reservoirs facili-
tate sufficient virus replication to sustain transmission. However,
high seroprevalence in all tested species, including short-lived
rodents, strongly suggests endemic transmission. Considering that
humans can sustain epidemic but not endemic transmission (Flies
et al., 2018), the only possible explanation for long-term endemic
circulation of RRV in Fiji is enzootic transmission in one or more
non-human vertebrate species. Although RRV transmission in non-
marsupials is poorly understood, horses are known to exhibit high,
long-lasting viremia with proven capacity to infect mosquitoes
(Stephenson et al., 2018). In our small sample of horses, all were
antibody-positive. Conversely, dogs do not appear to be efficient
reservoirs (Harley et al., 2001).
Given the extensive travel between Fiji and Australia, it is
possible that RRV was reintroduced into Fiji after 1980. Alterna-
tively, transmission might have continued at low levels after 1980,
but not recognized due to low clinical suspicion, limited diagnostic
capacity, and non-specific symptoms that overlap with those of
other diseases. All species tested are common, peridomestic, and
pan-global. Regardless of which species is the primary reservoir or
amplifying host(s), the study findings suggest RRV could poten-
tially become established in other areas with competent vectors. In
immunologically naïve populations, there is a risk of virgin soil
outbreaks such as those experienced in the Pacific Islands. Future
studies should focus on pathogen isolation to unequivocally
confirm RRV transmission and on the identification of competent
reservoirs and vectors. Laboratory diagnosis is crucial for surveil-
lance and the early detection of emergence and outbreaks.
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